AUG 6, 2026 · JOURNAL ARTICLE
Safety and Efficacy of GLP ‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes
Annals of Clinical and Translational Neurology
Retrospective cohort study with propensity matching showing GLP-1 RAs safe for seizure control and effective for weight loss in epilepsy patients, but limited by observational design and inability to detect smaller harmful effects.
Reported
Sample size610
Primary endpoint: Hazard ratio fo…0.92
95% CI0.68–1.23